Back to Studies
P1092
Phase IV Evaluation of the Steady State Pharmacokinetics of Zidovudine, Lamivudine, and Lopinavir/Ritonavir in Severely Malnourished HIV-1 Infected Children
Primary Protocol Team Members
Summary
P1092 is a Phase IV, multi-center, pharmacokinetic study of zidovudine (ZDV), lamivudine (3TC), and lopinavir/ritonavir (LPV/r) in severely malnourished HIV-infected children (ages 6 to < 36 months). The study is designed to assess the pharmacokinetic exposure, safety, and tolerability of ZDV, 3TC, and LPV/r in severely malnourished children compared to children with normal nutrition.
Loading study documents...
Loading study sites...
Loading study protocol team...
Loading study press...
Loading study publications/presentations...